[go: up one dir, main page]

BG61752B1 - Аерозолни състави под налягане - Google Patents

Аерозолни състави под налягане Download PDF

Info

Publication number
BG61752B1
BG61752B1 BG98681A BG9868194A BG61752B1 BG 61752 B1 BG61752 B1 BG 61752B1 BG 98681 A BG98681 A BG 98681A BG 9868194 A BG9868194 A BG 9868194A BG 61752 B1 BG61752 B1 BG 61752B1
Authority
BG
Bulgaria
Prior art keywords
composition according
polymer
pvp
sodium
propellant
Prior art date
Application number
BG98681A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98681A (bg
Inventor
Suresh N. Mistry
Mark Gibson
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG61752(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919120396A external-priority patent/GB9120396D0/en
Priority claimed from GB919120675A external-priority patent/GB9120675D0/en
Priority claimed from GB919124661A external-priority patent/GB9124661D0/en
Priority claimed from GB929203212A external-priority patent/GB9203212D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of BG98681A publication Critical patent/BG98681A/bg
Publication of BG61752B1 publication Critical patent/BG61752B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG98681A 1991-09-25 1994-03-24 Аерозолни състави под налягане BG61752B1 (bg)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB919120396A GB9120396D0 (en) 1991-09-25 1991-09-25 Formulations
GB919120675A GB9120675D0 (en) 1991-09-28 1991-09-28 Formulation
GB919124661A GB9124661D0 (en) 1991-11-19 1991-11-19 Formulations
GB929203212A GB9203212D0 (en) 1992-02-14 1992-02-14 Pharmaceutical formulations
PCT/GB1992/001749 WO1993005765A1 (en) 1991-09-25 1992-09-23 Pressurised aerosol compositions

Publications (2)

Publication Number Publication Date
BG98681A BG98681A (bg) 1995-02-28
BG61752B1 true BG61752B1 (bg) 1998-05-29

Family

ID=27450754

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98681A BG61752B1 (bg) 1991-09-25 1994-03-24 Аерозолни състави под налягане

Country Status (28)

Country Link
US (1) US6641800B1 (xx)
EP (2) EP0534731A1 (xx)
JP (1) JP3142136B2 (xx)
KR (1) KR100275426B1 (xx)
CN (1) CN1050285C (xx)
AT (1) ATE132739T1 (xx)
AU (1) AU654397B2 (xx)
BG (1) BG61752B1 (xx)
BR (1) BR9206549A (xx)
CA (1) CA2119932C (xx)
CZ (1) CZ282506B6 (xx)
DE (1) DE69207606T3 (xx)
DK (1) DK0605578T4 (xx)
ES (1) ES2082507T5 (xx)
FI (1) FI110407B (xx)
GR (2) GR3019098T3 (xx)
HU (2) HUT67480A (xx)
IL (1) IL103238A (xx)
MX (1) MX9205483A (xx)
MY (1) MY108309A (xx)
NO (1) NO307124B1 (xx)
NZ (1) NZ244439A (xx)
RO (1) RO114735B1 (xx)
RU (1) RU2122852C1 (xx)
SK (1) SK279456B6 (xx)
TW (1) TW216442B (xx)
UA (1) UA41873C2 (xx)
WO (1) WO1993005765A1 (xx)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
GB9214819D0 (en) * 1992-07-13 1992-08-26 Minnesota Mining & Mfg Valve assemblies
DE69413955T2 (de) * 1993-03-17 1999-04-01 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel
JPH08507792A (ja) * 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
WO1997001329A1 (de) 1995-06-27 1997-01-16 Boehringer Ingelheim Kg Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
EP1274433A1 (en) * 2000-04-13 2003-01-15 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
EP1280520B2 (en) 2000-05-10 2018-03-21 Novartis AG Phospholipid-based powders for drug delivery
BR0015884A (pt) 2000-05-22 2003-07-08 Chiesi Farma Spa Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ES2364636T3 (es) 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
US7544177B2 (en) * 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2005089738A2 (en) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
US20070031343A1 (en) * 2005-08-04 2007-02-08 Bonfour Charles A Iii Flavored medicinal inhalant
FR2895260B1 (fr) * 2005-12-23 2009-02-20 Servier Lab Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
AU2008214205B2 (en) 2007-02-11 2014-04-24 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
CA2723183C (en) 2008-05-06 2014-04-22 Richard W. Ducharme Apparatus and methods for delivering therapeutic agents
RU2565438C2 (ru) * 2008-11-04 2015-10-20 Сипла Лимитед Фармацевтическая аэрозольная композиция
AU2009330505A1 (en) 2008-12-23 2011-06-30 Cook Medical Technologies Llc Apparatus and methods for containing and delivering therapeutic agents
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
GB201402513D0 (en) * 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017067843A1 (de) * 2015-10-23 2017-04-27 Basf Se Formulierungen mit kontrollierter freisetzung von geruchsstoffen zur dermalen anwendung
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
BR112022023464A2 (pt) 2020-06-05 2022-12-20 Cook Medical Technologies Llc Endoscópios médicos para entregar agentes terapêuticos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US417295A (en) * 1889-12-17 Fabriken
AT274245B (de) 1967-05-17 1969-09-10 Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en) 1972-09-06 1977-05-24 Burroughs Wellcome Co. Cyclic sulphur compounds
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
CA1293929C (en) * 1986-03-10 1992-01-07 Kurt Burghart Pharmaceutical composition containing nifedipine
DE3767615D1 (de) 1986-03-10 1991-02-28 Kurt Burghart Pharmazeutikum sowie verfahren zu seiner herstellung.
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
US5658549A (en) 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery

Also Published As

Publication number Publication date
DK0605578T3 (da) 1996-03-25
HUT67480A (en) 1995-04-28
HK1005564A1 (en) 1999-01-15
FI110407B (fi) 2003-01-31
CN1071832A (zh) 1993-05-12
SK279456B6 (sk) 1998-11-04
NO307124B1 (no) 2000-02-14
NZ244439A (en) 1994-01-26
CA2119932A1 (en) 1993-04-01
WO1993005765A1 (en) 1993-04-01
CA2119932C (en) 2002-05-21
CZ282506B6 (cs) 1997-07-16
MY108309A (en) 1996-09-30
CZ69594A3 (en) 1995-11-15
DE69207606T3 (de) 2000-03-16
AU2647192A (en) 1993-04-27
EP0534731A1 (en) 1993-03-31
US6641800B1 (en) 2003-11-04
ES2082507T3 (es) 1996-03-16
IL103238A0 (en) 1993-02-21
RO114735B1 (ro) 1999-07-30
AU654397B2 (en) 1994-11-03
FI941388A0 (fi) 1994-03-25
DK0605578T4 (da) 2000-03-06
NO941077D0 (no) 1994-03-24
JPH07502262A (ja) 1995-03-09
DE69207606D1 (de) 1996-02-22
IL103238A (en) 1995-07-31
ATE132739T1 (de) 1996-01-15
GR3019098T3 (en) 1996-05-31
EP0605578B2 (en) 1999-09-22
KR100275426B1 (ko) 2001-03-02
BG98681A (bg) 1995-02-28
CN1050285C (zh) 2000-03-15
GR3032103T3 (en) 2000-03-31
ES2082507T5 (es) 1999-11-16
UA41873C2 (uk) 2001-10-15
TW216442B (en) 1993-11-21
HU210818A9 (en) 1995-08-28
FI941388L (fi) 1994-03-25
SK34094A3 (en) 1994-11-09
EP0605578A1 (en) 1994-07-13
BR9206549A (pt) 1995-10-17
RU2122852C1 (ru) 1998-12-10
HU9400853D0 (en) 1994-06-28
EP0605578B1 (en) 1996-01-10
DE69207606T2 (de) 1996-06-27
NO941077L (no) 1994-05-18
JP3142136B2 (ja) 2001-03-07
MX9205483A (es) 1993-05-01

Similar Documents

Publication Publication Date Title
BG61752B1 (bg) Аерозолни състави под налягане
US6123924A (en) Pressurized aerosol inhalation compositions
US5846521A (en) Pressurized solvent-free drug aerosol compositions containing hydrofluorocarbon propellants
AU726382B2 (en) Medicinal aerosol formulations of formoterol
JP2006312651A (ja) オキシカルバゼピン含有懸濁剤
HUP0204520A2 (en) Pharmaceutical composition containing esmolol and process for its preparation
US7838034B2 (en) Intravenous pharmaceutical form of administration
HK1005564B (en) Pressurised aerosol compositions
Kumar et al. Review on Pharmaceutical Suspension
AU2004203644A1 (en) Pharmaceutical compositions
IL98666A (en) Pressurised aerosol compositions